TMO

673.20

1.53% 10.16

Pre-mercato: 682.72 9.52 +1.41%

Thermo Fisher Scientific Inc (TMO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$663.04

Aprire:

$664.01

Volume 24 ore:

2.49M

Relative Volume:

1.18

Capitalizzazione di mercato:

$248.91B

Reddito:

$45.20B

Utile/perdita netta:

$6.87B

Rapporto P/E:

37.01

EPS:

18.1888

Flusso di cassa netto:

$6.75B

1 W Prestazione:

+3.25%

1M Prestazione:

+4.96%

6M Prestazione:

+26.62%

1 anno Prestazione:

+27.53%

Intervallo 1D:

$0.00

Intervallo di 1 settimana:

$644.16

$681.50

Portata 52W:

$435.27

$694.33

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Nome

Thermo Fisher Scientific Inc

Settore

Healthcare (1051)

Industria

Diagnostics & Research (44)

Telefono

(781) 622-1000

Indirizzo

168 THIRD AVENUE, WALTHAM, MA

Dipendente

125,000

Cinguettio

@thermofisher

Prossima data di guadagno

2026-10-21

Ultimi documenti SEC

TMO's Discussions on Twitter

Compare TMO vs DHR, NTRA, A, IQV

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TMO Thermo Fisher Scientific Inc	673.20	248.91B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	224.69	157.95B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	394.75	56.90B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	174.00	49.06B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	262.01	43.13B	16.63B	1.39B	2.12B	8.0674

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-09-09	Aggiornamento	UBS	Neutral → Buy
2026-09-03	Iniziato	CLSA	Outperform
2026-06-26	Ripresa	Bernstein	Mkt Perform
2026-06-11	Iniziato	Piper Sandler	Neutral
2026-06-03	Downgrade	HSBC Securities	Buy → Hold
2026-06-02	Ripresa	Wolfe Research	Outperform
2026-05-15	Ripresa	RBC Capital Mkts	Sector Perform
2026-03-27	Iniziato	DZ Bank	Buy
2025-12-11	Aggiornamento	Citigroup	Neutral → Buy
2025-12-09	Iniziato	Goldman	Buy
2025-12-08	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2025-12-02	Ripresa	Morgan Stanley	Overweight
2025-12-01	Aggiornamento	HSBC Securities	Hold → Buy
2025-09-11	Aggiornamento	Barclays	Equal Weight → Overweight
2025-08-19	Iniziato	William Blair	Outperform
2025-07-24	Downgrade	HSBC Securities	Buy → Hold
2025-07-11	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2025-07-09	Downgrade	UBS	Buy → Neutral
2025-01-10	Aggiornamento	Bernstein	Mkt Perform → Outperform
2024-12-23	Iniziato	Scotiabank	Sector Perform
2024-10-14	Iniziato	Redburn Atlantic	Buy
2024-10-01	Iniziato	Stephens	Overweight
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-06-03	Ripresa	Jefferies	Buy
2024-03-18	Ripresa	Citigroup	Neutral
2024-01-24	Downgrade	Barclays	Overweight → Equal Weight
2024-01-08	Downgrade	Bernstein	Outperform → Mkt Perform
2023-12-18	Iniziato	HSBC Securities	Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-10-26	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-10-25	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2023-09-28	Iniziato	Bernstein	Outperform
2023-09-06	Ripresa	Citigroup	Buy
2023-07-19	Iniziato	Raymond James	Outperform
2023-07-19	Reiterato	Robert W. Baird	Outperform
2023-07-13	Aggiornamento	Credit Suisse	Neutral → Outperform
2023-04-04	Reiterato	Barclays	Overweight
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-10-27	Downgrade	The Benchmark Company	Buy → Hold
2022-08-25	Iniziato	Credit Suisse	Neutral
2022-04-25	Downgrade	Wells Fargo	Equal Weight → Underweight
2022-01-26	Ripresa	Barclays	Overweight
2021-10-20	Aggiornamento	Citigroup	Neutral → Buy
2021-10-15	Ripresa	Cowen	Outperform
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-07-16	Iniziato	The Benchmark Company	Buy
2021-03-18	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Iniziato	Barclays	Overweight
2021-01-08	Aggiornamento	Credit Suisse	Neutral → Outperform
2020-12-16	Downgrade	Citigroup	Buy → Neutral
2020-12-02	Iniziato	Goldman	Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-09-14	Iniziato	Morgan Stanley	Overweight
2020-08-20	Ripresa	JP Morgan	Overweight
2020-07-15	Aggiornamento	Cleveland Research	Neutral → Buy
2020-07-07	Reiterato	Needham	Buy
2020-04-23	Reiterato	Needham	Buy
2020-01-31	Reiterato	Needham	Buy
2020-01-22	Iniziato	Credit Suisse	Neutral
2020-01-08	Iniziato	Wells Fargo	Equal Weight
2020-01-07	Iniziato	Citigroup	Buy
2019-11-15	Iniziato	Stifel	Buy
2019-07-25	Reiterato	Needham	Buy
2019-07-16	Downgrade	Needham	Strong Buy → Buy
2019-05-30	Iniziato	Wolfe Research	Outperform
2019-05-23	Reiterato	Needham	Strong Buy
2019-04-22	Reiterato	Needham	Strong Buy
2019-04-16	Reiterato	BofA/Merrill	Buy

Mostra tutto

Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie

Oct 14, 2026

Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.

Oct 14, 2026

Thermo Fisher Scientific stock pre-market at EUR 592.70 - ad-hoc-news.de

Oct 14, 2026

Oct 13, 2026

Biotech and Pharma Rebound Strengthen Thermo’s (TMO) Organic Growth - Yahoo Finance

Oct 13, 2026

Thermo Fisher to Report Q3 Earnings: What's in the Cards? - Zacks Investment Research

Oct 13, 2026

Thermo Fisher to Report Q3 Earnings: What's in the Cards? - TradingView

Oct 13, 2026

Thermo Fisher’s Expanded Drug Lifecycle Role Might Change The Case For Investing In Thermo Fisher Scientific (TMO) - Yahoo Finance

Oct 13, 2026

TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $760 From $675 - www.marketscreener.com

Oct 13, 2026

Oct 12, 2026

All You Need to Know About Thermo Fisher (TMO) Rating Upgrade to Buy - Zacks Investment Research

Oct 12, 2026

Thermo Fisher Scientific stock trades at EUR 587.70, volume is 4.1 percent of average - ad-hoc-news.de

Oct 12, 2026

Morgan Stanley Adjusts Price Target on Thermo Fisher Scientific to $730 From $650 - marketscreener.com

Oct 12, 2026

BofA raises Thermo Fisher target to USD 745 from USD 650 for Thermo Fisher Scientific stock - ad-hoc-news.de

Oct 12, 2026

Thermo Fisher Scientific stock pre-market at EUR 587.40 - ad-hoc-news.de

Oct 12, 2026

Oct 11, 2026

Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up? - Yahoo Finance

Oct 11, 2026

Oct 09, 2026

Thermo Fisher Scientific Inc Stock 12‑Month Price Target Raised to $682.12, Implies 5% Upside - TradingView

Oct 09, 2026

Thermo Fisher Scientific's Q3 2026 Earnings: What to Expect - Barchart.com

Oct 09, 2026

Global Decentralized Clinical Trials Market Size, Trends, and Forecast, 2025-2030 | AI, Wearables, and Cloud-Based Platforms Fuel 13.7% CAGR to $18.8 Billion - GlobeNewswire Inc.

Oct 09, 2026

Oct 08, 2026

Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch

Oct 08, 2026

What Could Thermo Fisher Scientific (TMO) Change With Its New Digital CMC Consortium? - Yahoo Finance

Oct 08, 2026

Why Thermo Fisher Scientific (TMO) Is Back In The Spotlight - Yahoo Finance

Oct 08, 2026

Oct 07, 2026

Thermo Fisher Scientific Inc. (1TMO.MI) stock price, news, quote and history - Yahoo Finance UK

Oct 07, 2026

Thermo Fisher Scientific Inc. (1TMO.MI) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 07, 2026

Is This the Right Time to Add TMO Stock to Your Portfolio? - Zacks Investment Research

Oct 07, 2026

Oct 06, 2026

Thermo Fisher Scientific Inc. stock falls Tuesday, underperforms market - MarketWatch

Oct 06, 2026

JPMorgan Adds AmEx, Thermo Fisher and Liberty Energy to October Overweight Picks - BigGo Finance

Oct 06, 2026

Thermo Fisher Scientific stock heads into October 21 results after a 2.27 percent drop - AD HOC NEWS

Oct 06, 2026

Thermo Fisher Scientific (TMO): Strong Q3 Guidance and Broadening Demand Support Multi-Year Outlook - Yahoo Finance

Oct 06, 2026

Barclays Adjusts Thermo Fisher Scientific Price Target to $750 From $650, Maintains Overweight Rating - marketscreener.com

Oct 06, 2026

Quantum BioPharma Signs Contract with Thermo Fisher Scientific’s Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis - GlobeNewswire Inc.

Oct 06, 2026

Preparations begin for Quantum BioPharma's planned Phase 2 multiple sclerosis drug trial - Stock Titan

Oct 06, 2026

Exclusive: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial - Benzinga

Oct 06, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026 - BioSpace

Oct 06, 2026

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.

Oct 06, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026 - Business Wire

Oct 06, 2026

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - Zacks Investment Research

Oct 06, 2026

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific - TradingView

Oct 06, 2026

Oct 05, 2026